These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8313183)

  • 1. [Randomised comparison on the treatment of falciparum malaria with dihydroartemisinin and piperaquine].
    Guo XB
    Zhonghua Yi Xue Za Zhi; 1993 Oct; 73(10):602-4, 638. PubMed ID: 8313183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
    Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
    Tran TH; Dolecek C; Pham PM; Nguyen TD; Nguyen TT; Le HT; Dong TH; Tran TT; Stepniewska K; White NJ; Farrar J
    Lancet; 2004 Jan; 363(9402):18-22. PubMed ID: 14723988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China].
    Wang SQ; Christophel E; Lin SG; Meng F; Hu XM; Wang GZ; Liu J; Zeng LH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Feb; 26(1):50-2. PubMed ID: 18637586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of artemisinin suppositories and piperaquine phosphate in the treatment of falciparum malaria].
    Guo XB; Fu LC
    Zhong Xi Yi Jie He Za Zhi; 1989 Aug; 9(8):475-7, 453. PubMed ID: 2688937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam.
    Phuc BQ; Rasmussen C; Duong TT; Dong LT; Loi MA; Ménard D; Tarning J; Bustos D; Ringwald P; Galappaththy GL; Thieu NQ
    Emerg Infect Dis; 2017 Apr; 23(4):715-717. PubMed ID: 28322709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of compound dihydroartemisinin/piperaquine in treatment of uncomplicated falciparum malaria in Myanmar].
    Liu H; Yang HL; Zhang J; Li CF; Nie RH; Wang HY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2011 Aug; 29(4):296-8. PubMed ID: 21972607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.
    Thanh NV; Thuy-Nhien N; Tuyen NT; Tong NT; Nha-Ca NT; Dong LT; Quang HH; Farrar J; Thwaites G; White NJ; Wolbers M; Hien TT
    Malar J; 2017 Jan; 16(1):27. PubMed ID: 28086775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
    Ashley EA; Krudsood S; Phaiphun L; Srivilairit S; McGready R; Leowattana W; Hutagalung R; Wilairatana P; Brockman A; Looareesuwan S; Nosten F; White NJ
    J Infect Dis; 2004 Nov; 190(10):1773-82. PubMed ID: 15499533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.
    Byakika-Kibwika P; Ssenyonga R; Lamorde M; Blessborn D; Tarning J
    BMC Infect Dis; 2019 Dec; 19(1):1025. PubMed ID: 31795967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of dihydroartemisinin/piperaquine and artesunate monotherapy for the treatment of uncomplicated Plasmodium falciparum malaria in Central Vietnam.
    Rovira-Vallbona E; Van Hong N; Kattenberg JH; Huan RM; Hien NTT; Ngoc NTH; Guetens P; Hieu NL; Mai TT; Duong NTT; Duong TT; Phuc BQ; Xa NX; Erhart A; Rosanas-Urgell A
    J Antimicrob Chemother; 2020 Aug; 75(8):2272-2281. PubMed ID: 32437557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic efficacy and safety of compound dihydroartemisinin/piperaquine for uncomplicated Plasmodium falciparum infection in Laiza City of Myanmar bordering on China].
    Sun XD; Zhang ZX; Wang J; Deng Y; Yang YC; Lasi JH; Sun XY; Wang H
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2011 Oct; 29(5):372-5. PubMed ID: 24830201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in Vietnam.
    Nguyen DV; Nguyen QP; Nguyen ND; Le TT; Nguyen TD; Dinh DN; Nguyen TX; Bui D; Chavchich M; Edstein MD
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3534-7. PubMed ID: 19528277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria.
    Tangpukdee N; Krudsood S; Thanachartwet W; Chalermrut K; Pengruksa C; Srivilairit S; Silachamroon U; Wilairatana P; Phongtananant S; Kano S; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1085-91. PubMed ID: 16438129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria.
    Denis MB; Davis TM; Hewitt S; Incardona S; Nimol K; Fandeur T; Poravuth Y; Lim C; Socheat D
    Clin Infect Dis; 2002 Dec; 35(12):1469-76. PubMed ID: 12471565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of dihydroartemisinin-mefloquine on acute uncomplicated falciparum malaria.
    Wang W; Yang W; Micha ST
    Chin Med J (Engl); 2001 Jun; 114(6):612-3. PubMed ID: 11780437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.